Claret Asset Management Updates Quipt Home Medical Stake

Ticker: QIPT · Form: SC 13G/A · Filed: Jan 31, 2024 · CIK: 1540013

Quipt Home Medical Corp. SC 13G/A Filing Summary
FieldDetail
CompanyQuipt Home Medical Corp. (QIPT)
Form TypeSC 13G/A
Filed DateJan 31, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, healthcare-services

TL;DR

**Claret Asset Management just updated their Quipt Home Medical Corp. holdings.**

AI Summary

Claret Asset Management Corp. filed an amended SC 13G/A on January 31, 2024, indicating their ownership of Quipt Home Medical Corp. Common Shares as of December 31, 2023. This filing, an amendment number 2, updates their previous disclosures regarding their stake in Quipt Home Medical Corp. (formerly Protech Home Medical Corp. and Patient Home Monitoring Corp.). This matters to investors because it provides transparency into institutional ownership, which can signal confidence or changes in sentiment from a significant holder.

Why It Matters

This filing shows that Claret Asset Management Corp. continues to hold a position in Quipt Home Medical Corp., providing insight into institutional investor activity for current and prospective shareholders.

Risk Assessment

Risk Level: low — This is a routine amendment filing by an institutional investor, not indicating any immediate significant risk.

Analyst Insight

Investors should note that Claret Asset Management Corp. is maintaining its position in Quipt Home Medical Corp. This is a routine update and doesn't signal an immediate buy or sell, but rather confirms continued institutional interest. Further analysis of the full 13G filing would be needed to determine the exact percentage of ownership and any changes from previous filings.

Key Numbers

  • 74880P104 — CUSIP Number (identifies the Common Shares of Quipt Home Medical Corp.)
  • 005-93252 — SEC File Number (identifies Quipt Home Medical Corp.'s registration with the SEC)
  • 2 — Amendment Number (indicates this is the second amendment to Claret Asset Management Corp.'s Schedule 13G filing)

Key Players & Entities

  • Claret Asset Management Corp. (company) — the reporting person filing the SC 13G/A
  • Quipt Home Medical Corp. (company) — the subject company whose shares are being reported
  • Protech Home Medical Corp. (company) — former name of Quipt Home Medical Corp. as of 20200714
  • Patient Home Monitoring Corp. (company) — former name of Quipt Home Medical Corp. as of 20120119
  • December 31, 2023 (date) — the date of the event which requires the filing of this statement

FAQ

Who filed this SC 13G/A amendment?

Claret Asset Management Corporation filed this SC 13G/A amendment, as stated in the 'NAME OF REPORTING PERSON' section of the filing.

What company's shares are the subject of this filing?

The subject company is Quipt Home Medical Corp., as indicated by 'Name of Issuer' in the filing. It was formerly known as Protech Home Medical Corp. and Patient Home Monitoring Corp.

What is the CUSIP number for the securities mentioned in this filing?

The CUSIP number for the Common Shares of Quipt Home Medical Corp. is 74880P104, as listed on the cover page of the filing.

What was the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, according to the cover page of the filing.

What type of securities are being reported in this filing?

The filing reports on 'Common Shares' of Quipt Home Medical Corp., as specified under 'Title of Class of Securities' on the cover page.

Filing Stats: 711 words · 3 min read · ~2 pages · Grade level 8.3 · Accepted 2024-01-30 17:57:58

Filing Documents

From the Filing

SC 13G/A 1 d756315dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Quipt Home Medical Corp. (Name of Issuer) Common Shares (Title of Class of Securities) 74880P104 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 74880P104 13G Page 2 of 5 Pages 1. NAME OF REPORTING PERSON Claret Asset Management Corporation 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Canada NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER 4,310,318 6. SHARED VOTING POWER 7. SOLE DISPOSITIVE POWER 4,310,318 8. SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,310,318 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.24% 12. TYPE OF REPORTING PERSON IA CUSIP No. 74880P104 13G Page 3 of 5 Pages Item1(a). Name of Issuer: Quipt Home Medical Corp. Item1(b). Address of Issuers Principal Executive Offices: 1019 Town Drive, Wilder, KY 41076 Item2(a). Name of Person Filing: Claret Asset Management Corporation (CAMC) Item2(b). Address of Principal Business Office or, if none, Residence: 900 de Maisonneuve O., Suite 1900, Montreal, Quebec, Canada H3A 0A8 Item2(c). Citizenship: Quebec, Canada Item2(d). Title of Class of Securities: Common Shares Item2(e). CUSIP Number: 74880P104 Item3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), indicate type of person filing. An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E) Item4. (a) Amount beneficially owned: 4,310,318 (b) Percent of class: 10.24% (c) Number of shares as to which such person has: (i) Sole power to vote or direct the vote: 4,310,318 (ii) Shared power to vote or direct the vote: (iii) Sole power to dispose or to direct the disposition of: 4,310,318 (iv) Shared power to dispose or to direct the disposition of: CUSIP No. 74880P104 13G Page 4 of 5 Pages Percent of class is based on (i) the number of Common Shares that may be deemed to be beneficially owned by CAMC as of December 31, 2023, and (ii) the number of Common Shares outstanding as of December 21, 2023 (42,102,471 shares) as reported by the Issuer in its Managements Discussion and Analysis included as an exhibit to its Form 40-F filed with the Securities and Exchange Commission on December 22, 2023. Item5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following []. Item6. Other persons have the right to receive proceeds from the sale of securities reflected herein. Item7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item8. Identification and Classification of Members of the Group. Not applicable. Item9. Notice of Dissolution of Group. Not applicable. Item10. Certifications. Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 29, 2024 Claret Asset Management Corporation By: /s/ Monique Gravel Name: Monique Gravel Title: Chief Executive Officer

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.